Page last updated: 2024-10-17

cytosine and Extensively Drug-Resistant Tuberculosis

cytosine has been researched along with Extensively Drug-Resistant Tuberculosis in 1 studies

Extensively Drug-Resistant Tuberculosis: Tuberculosis resistant to ISONIAZID and RIFAMPIN and at least three of the six main classes of second-line drugs (AMINOGLYCOSIDES; polypeptide agents; FLUOROQUINOLONES; THIOAMIDES; CYCLOSERINE; and PARA-AMINOSALICYLIC ACID) as defined by the CDC.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Singh, K1
Sharma, S1
Banerjee, T1
Gupta, A1
Anupurba, S1

Other Studies

1 other study available for cytosine and Extensively Drug-Resistant Tuberculosis

ArticleYear
Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates.
    BMC microbiology, 2022, 10-03, Volume: 22, Issue:1

    Topics: Agar; Antitubercular Agents; Clofazimine; Cytosine; Drug Resistance, Multiple, Bacterial; Extensivel

2022